●
BBIO
BridgeBio Pharma, Inc.
$52.50M
Single sell
Discretionary Insider Activity
Date:
07/18/2023
Insiders:
VIKING GLOBAL INVESTORS LP, a 10%+ owner
Prior trend:
23 months of no clear discretionary insider activity

Summary

A $52.50M single sell for BridgeBio Pharma, Inc. (BBIO) on 07/18/2023 after 23 months of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
● Sell $52.50M 07/19/2023 VIKING GLOBAL INVESTORS LP + 6 A 10%+ owner 0001140361-23-035288

Transactions

Action Amount Date Insider Security Type SEC Code
● Sell $52.50M 07/18/2023 VIKING GLOBAL INVESTORS LP Common Stock Discretionary Sale

Stats

Prior max multiple:
24.4
Prior median multiple:
44.9

Metadata

Signal ID:
NwEfe2xoz0IyvZI0
Detected on:
07/17/2023